Breast Cancer,TNBC (Triple Negative Breast Cancer) Avelumab Improves Survival in High-Risk TNBC: A-Brave Jun 11, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) ZNF680-Driven REG3A: A Novel Breast Cancer Target Jun 07, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) EV in Heavily Treated TNBC: Manageable Safety & Antitumor Activity Jun 03, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Triple-loaded Nanoparticles: Promising Therapy for BC May 28, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Tackling Resistance in aTNBC: Advancing Treatment Strategies May 16, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Addressing Disparities: Improving Treatment and Survival Equity May 10, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Prognostic Signature of Stemness-Related lncRNAs in TNBC May 08, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Enhancing TNBC Treatment: CM-hUCESC & Paclitaxel Synergy Apr 29, 2024
